In November 2025, within the framework of the FIHAV 2025 International Industrial Exhibition in Havana, a solemn signing of a joint venture agreement took place between the State-owned enterprise ACADEMPHARM (Republic of Belarus) and the Cuban company MedSol, part of the BioCubaFarma holding (Republic of Cuba).
The signing of the Agreement was an important step in the development of bilateral cooperation in the field of pharmaceuticals and medical technologies. The new company will focus on:
development of joint scientific and production projects;
expanding the range of modern medicines;
strengthening the positions of Belarusian and Cuban pharmaceutical products on international markets;
exchange of experience and implementation of innovative technologies in production.
The cooperation between ACADEMPHARM and BioCubaFarma is of strategic importance for both countries, opening up new opportunities in the pharmaceutical industry and ensuring public access to high-quality and effective drugs.
